Types of Cancer We Treat

Primary Central Nervous System Lymphoma in Adults

A multidisciplinary team works together to provide you with personalized care for primary central nervous system lymphoma. This rare, fast-growing type of non-Hodgkin lymphoma can start in the brain, eyes, spinal cord, or meninges, which are the layers of tissue that cover and protect the brain and spinal cord. We use the newest genetic tests to determine what therapies are best for you. Your treatment plan may include chemotherapy, targeted drugs, and radiation therapy. You may also be eligible to participate in clinical trials, which offer access to promising new medications.

Find a Doctor & Schedule
Diagnosis
Medication
Radiation Therapy

Clinical Trials and Research Studies

Phase 2

A Phase 2 Trial of the Combination of Polatuzumab Vedotin Venetoclax and Rituximab and Hyaluronidase Human for Relapsed and Refractory Mantle Cell Lymphoma

Learn More

Phase 2

DAY101-001/PNOC026/FIREFLY-1: A Phase 2 Open-Label Multicenter Study to Evaluate the Safety and Efficacy of the Oral Pan-RAF Inhibitor DAY101 in Pediatric Patients with BRAF-Altered Recurrent or Progressive Low-Grade Glioma

Learn More

Phase 1

A PHASE Ib STUDY EVALUATING THE SAFETY EFFICACY AND PHARMACOKINETICS OF VENETOCLAX IN COMBINATION WITH POLATUZUMAB VEDOTIN PLUS RITUXIMAB (R) AND CYCLOPHOSPHAMIDE DOXORUBICIN PREDNISONE (CHP) IN PATIENTS WITH UNTREATED BCL-2 IMMUNOHISTOCHEMISTRY (IHC) POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA

Learn More

Phase 2

ANBL19P1: A Pilot Study of Dinutuximab Sargramostim (GM-CSF) and Isotretinoin in Combination with Irinotecan and Temozolomide in the Post-Consolidation Setting for High-Risk Neuroblastoma

Learn More
View All Related Clinical Trials (18)